Study of Bulevirtide in Participants Who Have Normal or Impaired Liver Function

Clinical trial NCT05765344 · COMPLETED

Trial details

NCT number: NCT05765344
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment Healthy

Start date: 2023-03-15
Primary completion: 2025-01-10
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.